Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C1-esterase inhibitor in human endotoxemia
NCT01766414Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2013
- Primary completion
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of C1 inhibitor, human in sepsis, sponsored by Radboud University Medical Center. Started Sep 2013; status: completed.
02
Drugs
C1 inhibitor, human
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT01766414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766414.